Singapore legislation

Regulation 19

of Healthcare Services (Blood Banking Service) Regulations 2021

Regulation 19

Donor testing

Amended byS 388/2023 wef 26/06/2023S 388/2023 wef 26/06/2023S 388/2023 wef 26/06/2023

Subregulation 1

Amended byS 388/2023 wef 26/06/2023S 388/2023 wef 26/06/2023S 388/2023 wef 26/06/2023

A licensee must —

(a)

ensure that all tests conducted on donors by the licensee are appropriate, accurate and up‑to‑date;

(b)

before providing any test or implementing any test method, evaluate whether the test or test method produces accurate results; (c)regularly evaluate and validate the effectiveness and performance of the tests mentioned in sub‑paragraph (a) by participating in a relevant external quality assurance programme; and

(d)

ensure that a Clinical Governance Officer, or such other suitably qualified personnel designated by a Clinical Governance Officer —

(i)

reviews the results of the external quality assurance programme mentioned in sub-paragraph (c); and

(ii)

implements appropriate and effective actions to address any weakness or inadequacy in the provision of any test mentioned in sub-paragraph (a).

Subregulation 2

For the purposes of paragraph (1)(b), the licensee must —

(a)

evaluate the test or test method against the specifications provided by the manufacturer of that test or test method; or

(b)

establish the performance of the test or test method to ensure acceptable reproducibility, accuracy, sensitivity, specificity and precision in relation to the expected use of the test or test method.